Guardian Pharmacy Services (NYSE:GRDN) Reaches New 12-Month High – What’s Next?

Guardian Pharmacy Services, Inc. (NYSE:GRDNGet Free Report) hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $34.42 and last traded at $33.75, with a volume of 204629 shares changing hands. The stock had previously closed at $29.75.

Analysts Set New Price Targets

A number of brokerages have weighed in on GRDN. Weiss Ratings reissued a “sell (d+)” rating on shares of Guardian Pharmacy Services in a report on Wednesday, October 8th. Oppenheimer assumed coverage on shares of Guardian Pharmacy Services in a research report on Friday, October 10th. They set an “outperform” rating and a $30.00 price objective on the stock. Truist Financial raised their target price on Guardian Pharmacy Services from $28.00 to $30.00 and gave the stock a “buy” rating in a research report on Friday, September 26th. Finally, Wall Street Zen lowered Guardian Pharmacy Services from a “strong-buy” rating to a “buy” rating in a research report on Sunday. Three research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $29.33.

Read Our Latest Stock Report on Guardian Pharmacy Services

Guardian Pharmacy Services Price Performance

The stock has a market capitalization of $2.11 billion, a price-to-earnings ratio of -21.94 and a beta of 0.96. The stock’s 50 day simple moving average is $26.82 and its 200-day simple moving average is $23.92.

Institutional Investors Weigh In On Guardian Pharmacy Services

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. State of Alaska Department of Revenue acquired a new position in shares of Guardian Pharmacy Services during the 3rd quarter worth about $30,000. Ameritas Investment Partners Inc. increased its holdings in shares of Guardian Pharmacy Services by 26.5% during the 3rd quarter. Ameritas Investment Partners Inc. now owns 1,647 shares of the company’s stock worth $43,000 after purchasing an additional 345 shares during the period. Parkside Financial Bank & Trust acquired a new position in shares of Guardian Pharmacy Services during the second quarter valued at about $41,000. Raymond James Financial Inc. acquired a new position in shares of Guardian Pharmacy Services in the second quarter valued at $43,000. Finally, Police & Firemen s Retirement System of New Jersey boosted its stake in Guardian Pharmacy Services by 76.8% during the second quarter. Police & Firemen s Retirement System of New Jersey now owns 2,444 shares of the company’s stock worth $52,000 after buying an additional 1,062 shares in the last quarter.

Guardian Pharmacy Services Company Profile

(Get Free Report)

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.

See Also

Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.